mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-07 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-07 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
6e-07 |
mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
1e-06 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
1e-06 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
Pazopanib |
FIMM |
pan-cancer |
AAC |
0.8 |
1e-06 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |